ClinConnect ClinConnect Logo
Search / Trial NCT01794221

The Role of 2-octyl Cyanoacrylate in Prevention of Recurrent Adhesions After Circumcision

Launched by CHILDREN'S MERCY HOSPITAL KANSAS CITY · Feb 15, 2013

Trial Information

Current as of June 06, 2025

Completed

Keywords

Circumcision 2 Octyl Cyanoacrylate Phimosis

ClinConnect Summary

The objective of this study is to evaluate whether 2-octyl cyanoacrylate skin adhesive decreased the incidence of recurrent adhesions after circumcision. The investigators hypothesize that the incidence of recurrent adhesions will be decreased with use of 2-octyl cyanoacrylate skin adhesive.

Secondary Objective(s) To assess parent satisfaction and comfort level after circumcision with use of 2-octyl cyanoacrylate skin adhesive and compare to those undergoing circumcision without the use of 2-octyl cyanoacrylate skin adhesive.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • All patients undergoing circumcision
  • Only male patients under the age of 7 years will be eligible
  • Exclusion Criteria:
  • Any patient over 7 years of age
  • Previous circumcision
  • Any parents who are not English language speaking

About Children's Mercy Hospital Kansas City

Children's Mercy Hospital Kansas City is a renowned pediatric healthcare institution dedicated to advancing the health and well-being of children through innovative research and clinical trials. As a leading sponsor of clinical trials, the hospital focuses on developing and testing new treatments and therapies that address a wide range of pediatric conditions. With a commitment to excellence in patient care and a collaborative approach to research, Children's Mercy is at the forefront of pediatric medicine, striving to improve outcomes and enhance the quality of life for children and their families.

Locations

Kansas City, Missouri, United States

Patients applied

0 patients applied

Trial Officials

Shawn D St. Peter, MD

Principal Investigator

Children's Mercy Hospital and Clinics

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials